Journal
JOURNAL OF INFECTIOUS DISEASES
Volume 186, Issue 9, Pages 1371-1375Publisher
UNIV CHICAGO PRESS
DOI: 10.1086/344322
Keywords
-
Categories
Funding
- NIAID NIH HHS [1 R01 AI50240-01] Funding Source: Medline
Ask authors/readers for more resources
Macrophage migration inhibitory factor (MIF) may play a role in immune responses to malaria during pregnancy by virtue of its ability to activate macrophages and to overcome the immunosuppressive effect of glucocorticoids. The present study investigated whether plasma MIF levels are altered in pregnant women with placental malaria (PM) and/or human immunodeficiency virus (HIV) infection. For the first time it is demonstrated that MIF levels in the intervillous blood (IVB) plasma were significantly elevated, compared with that in both peripheral plasma (similar to500-fold) and cord plasma (4.6-fold; P < .01). IVB mononuclear cells also produced significantly higher levels of MIF, compared with that of peripheral blood mononuclear cells. PM was associated with increased levels of MIF in the IVB plasma (P<.02). Primigravid and secundigravid women had significantly higher levels of MIF in their IVB plasma than did multigravid women (P<.05). HIV infection did not significantly alter MIF levels in any site examined.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available